Skip links

VALIDATION

Multiple studies and commercial installations demonstrate C-POLAR™ material effectively captures, inactivates, and eradicates viruses, microorganisms, and pollens, with up to 99.99% efficiency

Lab Validation

The study showed C-POLAR™ material eradicated 92% of Staphylococcus aureus after a 10-minute incubation period. The input of pathogens was close to 100x higher than the ISO 20743:2013 standard.

92%
ERADICATION

The study showed filters protected by C-POLAR™ significantly improved collection efficiency and substantially reduced viable bovine coronavirus concentration by 99.3% in a single-pass, fast air-flow wind tunnel.

99.3%
CAPTURE

The study showed C-POLAR™ material eradicated >99.6% of SARS-CoV-2 within 30 minutes (98% within 5 minutes). In one of the biological replicates, researchers achieved 100% virus eradication.

99.6%
ERADICATION

The study showed C-POLAR™ material eradicated >99.9% of multiple bacterial pathogens within 1 minute.

99.9%
ERADICATION

The study showed C-POLAR™ material demonstrated a viral filtration efficiency (VFE) of >99.9%.

99.9%
CAPTURE

The study showed C-POLAR™ material demonstrated a viral filtration efficiency (VFE) of >99.9%.

99.9%
CAPTURE

COMMERCIAL VALIDATION

Working in partnership with Hong Kong Metropolitan University, we installed filters protected by C-POLAR™ in five dense foot traffic locations in Hong Kong: International Commerce Center, Central Building, K11 MUSEA, 1 Duddell Street, and China Minmetals Tower.

Studies showed filters protected by C-POLAR™ demonstrated strong effectiveness against pathogens of up to 99.9999%, even after 60 days of intensive, real-world commercial use in bioaerosol and particulate rich environments.

Our technology’s efficacy and safety has been tested and verified by leading medical and regulatory institutions in the United States, Czech Republic, Hong Kong, Canada, and United Kingdom.